Incannex secures A$13m placement but share price dives by Steve Jones December 5, 2022April 29, 2024 Incannex Healthcare has bolstered its finances with a A$13m institutional placement from a consortium of US […]
Company news: LGP; Cann Global; Medcan; Incannex; Medlab; Emyria; RestoreMe; Releaf Group; Levin Health by Martin Lane and Steve Jones November 30, 2022April 29, 2024
Company news: Neurotech; Emyria; Cann Group; Incannex; Creso Pharma; Greenfern; Zelira; Organic Genetics by Martin Lane November 24, 2022April 29, 2024
Company news: Bod; Incannex; Medlab; Rua Bioscience; Emyria by Martin Lane October 20, 2022April 29, 2024
Company news: Cann Group; Cronos; Releaf Group; Rua Bioscience; Incannex by Martin Lane October 12, 2022April 29, 2024
Company news: MediCann Health; Creso Pharma; Botanix Pharmaceuticals; Incannex by Martin Lane September 7, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
Company news: MGC Pharma; Emyria; Incannex, IvyMed Clinic by Steve Jones August 17, 2022April 29, 2024
Incannex lists priority projects as deal completes for US biotech firm by Steve Jones August 9, 2022April 29, 2024
Company news: ANTG; MGC Pharma; Medlab Clinical; Bod; Creso Pharma; InhaleRx; Incannex by Martin Lane August 4, 2022April 29, 2024
